Llwytho...
Stereotactic Ablative Radiotherapy for Central and Ultra-Central Lung Tumors
Stereotactic ablative radiotherapy (SABR) has emerged as a standard-of-care treatment for patients with early stage non-small cell lung cancer (NSCLC) who are poor surgical candidates. Current evidence supports the consensus that lung SABR with BED ≥100 Gy leads to high local tumor control, and that...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Ther Radiol Oncol |
|---|---|
| Prif Awduron: | , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2019
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8054989/ https://ncbi.nlm.nih.gov/pubmed/33880444 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tro.2019.05.01 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|